Menu
Back to Journals » Journal of Blood Medicine » Volume 5
Journal of Blood Medicine
ISSN: 1179-2736
- View all (542)
- Volume 14, 2023 (19)
- Volume 13, 2022 (77)
- Volume 12, 2021 (107)
- Volume 11, 2020 (61)
- Volume 10, 2019 (54)
- Volume 9, 2018 (30)
- Volume 8, 2017 (24)
- Volume 7, 2016 (30)
- Volume 6, 2015 (31)
- Volume 5, 2014 (27)
- Volume 4, 2013 (21)
- Volume 3, 2012 (19)
- Volume 2, 2011 (18)
- Volume 1, 2010 (24)
Archive: Volume 5, 2014
Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes
El Sayed SM, Baghdadi H, Abou-Taleb A, Mahmoud HS, Maria RA, Ahmed NS, Helmy Nabo MM
Journal of Blood Medicine 2014, 5:219-237
Published Date: 30 October 2014
Optimal management of hemophilic arthropathy and hematomas
Lobet S, Hermans C, Lambert C
Journal of Blood Medicine 2014, 5:207-218
Published Date: 17 October 2014
Optimal management of hereditary hemorrhagic telangiectasia
Garg N, Khunger M, Gupta A, Kumar N
Journal of Blood Medicine 2014, 5:191-206
Published Date: 15 October 2014
The relationship between red blood cell distribution width and blood pressure in patients with type 2 diabetes mellitus in Lagos, Nigeria
Dada OA, Uche E, Akinbami A, Odesanya M, John-Olabode S, Adediran A, Oshinaike O, Ogbera AO, Okunoye O, Arogundade O, Aile K, Ekwere T
Journal of Blood Medicine 2014, 5:185-189
Published Date: 19 September 2014
Hemophilia A in Brazil – epidemiology and treatment developments
Ferreira AA, Leite IC, Bustamante-Teixeira MT, Guerra MR
Journal of Blood Medicine 2014, 5:175-184
Published Date: 25 September 2014
Seroprevalence of human T-lymphotropic virus antibodies among patients with lymphoid malignancies at a tertiary center in Lagos, Nigeria
Akinbami A, Durojaiye I, Dosunmu A, John-Olabode S, Adediran A, Oshinaike O, Uche E, Dada A, Odesanya M, Okunoye O
Journal of Blood Medicine 2014, 5:169-174
Published Date: 5 September 2014
The diagnosis and treatment of dyskeratosis congenita: a review
Fernández García MS, Teruya-Feldstein J
Journal of Blood Medicine 2014, 5:157-167
Published Date: 21 August 2014
Mixing and administration times of bypassing agents: observations from the Dosing Observational Study in Hemophilia (DOSE)
Maahs J, Donkin J, Recht M, Cooper DL
Journal of Blood Medicine 2014, 5:153-156
Published Date: 20 August 2014
Profile of pacritinib and its potential in the treatment of hematologic disorders
Hatzimichael E, Tsolas E, Briasoulis E
Journal of Blood Medicine 2014, 5:143-152
Published Date: 19 August 2014
Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II
Grouzi E
Journal of Blood Medicine 2014, 5:131-141
Published Date: 13 August 2014
Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience [Corrigendum]
Rodriguez Garzotto A, Cortijo Casacajares S, Pernaut C, Ruiz Ares GJ, Otero Blas I, Heine O, Turner M, Rebollo Laserna F, Cortes Funes H, Lorenz A
Journal of Blood Medicine 2014, 5:129-130
Published Date: 29 July 2014
Acute ST-segment elevation myocardial infarction in a young patient with essential thrombocythemia: a case with long-term follow-up report
Bhat T, Ahmed M, Baydoun H, Ghandour Z, Bhat A, McCord D
Journal of Blood Medicine 2014, 5:123-127
Published Date: 23 July 2014
Physical and psychosocial challenges in adult hemophilia patients with inhibitors
duTreil S
Journal of Blood Medicine 2014, 5:115-122
Published Date: 22 July 2014
Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?
Korte W
Journal of Blood Medicine 2014, 5:107-113
Published Date: 9 July 2014
Fluorescence resonance energy transfer-based real-time polymerase chain reaction method without DNA extraction for the genotyping of F5, F2, F12, MTHFR, and HFE
Martinez-Serra J, Robles J, Nicolàs A, Gutierrez A, Ros T, Amat JC, Alemany R, Vögler O, Abelló A, Noguera A, Besalduch J
Journal of Blood Medicine 2014, 5:99-106
Published Date: 25 June 2014
Umbilical cord blood banking: from personal donation to international public registries to global bioeconomy
Petrini C
Journal of Blood Medicine 2014, 5:87-97
Published Date: 18 June 2014
Hemophagocytic lymphohistiocytosis: review of etiologies and management
George MR
Journal of Blood Medicine 2014, 5:69-86
Published Date: 12 June 2014
Targeting GPVI as a novel antithrombotic strategy
Andrews RK, Arthur JF, Gardiner EE
Journal of Blood Medicine 2014, 5:59-68
Published Date: 21 May 2014
Fatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor
Haley KM, Russell TB, Boshkov L, Leger RM, Garratty G, Recht M, Nazemi KJ
Journal of Blood Medicine 2014, 5:55-58
Published Date: 15 May 2014
Back pain: the sole of presentation of sickle cell disease
Osman S, Khan S, Hendaus MA
Journal of Blood Medicine 2014, 5:49-53
Published Date: 8 May 2014
Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience
Rodriguez Garzotto A, Heine O, Turner M, Rebollo Laserna F, Lorenz A
Journal of Blood Medicine 2014, 5:43-48
Published Date: 28 April 2014
Inflammatory response following neutrophil recovery postchemotherapy in acute myeloid leukemia cases without evidence of infection: role of homing of neutrophils
Pawar RD, Williams T, Khera R, Eid A, Aljitawi OS, Dusing RW
Journal of Blood Medicine 2014, 5:37-41
Published Date: 10 March 2014
Applying spatial epidemiology to hematological disease using R: a guide for hematologists and oncologists
Kohno K, Narimatsu H, Otani K, Sho R, Shiono Y, Suzuki I, Kato Y, Fukao A, Kato T
Journal of Blood Medicine 2014, 5:31-36
Published Date: 5 March 2014
Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations
Ahrens I, Bode C
Journal of Blood Medicine 2014, 5:25-30
Published Date: 24 February 2014
Management of thrombotic thrombocytopenic purpura: current perspectives
Blombery P, Scully M
Journal of Blood Medicine 2014, 5:15-23
Published Date: 5 February 2014
Toward a patient-based paradigm for blood transfusion
Farrugia A, Vamvakas E
Journal of Blood Medicine 2014, 5:5-13
Published Date: 31 January 2014
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project
Lentz SR, Tandra A, Gut RZ, Cooper DL
Journal of Blood Medicine 2014, 5:1-3
Published Date: 13 January 2014